Sarcena, Martin L.
HRN: 21-40-13 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/09/2023
CEFTAZIDIME 1GM (VIAL)
02/09/2023
02/15/2023
IV
1g
Q8
CAP MR With Pleural Effusion Right
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes